4-methylumbelliferyl trimebutine sulfate

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug Name4-methylumbelliferyl trimebutine sulfate
Drug Alias Name4-MUST4c
ClassificationSmall molecules
Mechanisms of ActionOpioid receptors agonistsMuscarinic acetylcholine receptor antagonists
TargetsOpioid receptorsMuscarinic acetylcholine receptor
Therapy Area/IndicationsCholecystitisBiliary Dyskinesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesValenta Pharm Jsc
China Registration ClassN/A

Develop Information

Active CompaniesValenta Pharm Jsc
Inactive CompaniesN/A
Active IndicationsCholecystitisBiliary Dyskinesia
Inactive IndicationsN/A

Other Information

ATC CodeA03AA05
Related LinksN/A